The Anatomy of a Vaccine: The Path To Recovery?

[CremornePt]

Solid  article - for those who are reluctant to take the vaccine...

https://www.channelnewsasia.com/news/commentary/long-term-effects-covid-19-vaccine-pfizer-moderna-allergies-14270174

"While these “long-term” side effects may continue for a prolonged period of time, their onset, if they happen, would usually be within days to approximately six weeks after vaccination. There is no known side effect of any vaccine that pops up years later."

[mersaylee]

NIH is studying the brains of those who died without symptoms and found black spots in the blood vessels...😱

Also mentioned about "long hauler"...people who have recovered have different types of after effects with no fixed pattern...from sleeping difficulty, lost of balance, breathlessness etc 😱😱

We're really in a long haul with this pandemic 😰

[therock]

IMHO, casual leisurely travel won't be ready until 70% of the world accepts the vaccines, or gets some infection / herd immunity...

So that may mean a few more years before we fly for fun again... 

I met an SQ girl recently and told her to keep her current job at the frontline, stay grounded and not look to the skies yet... she was crestfallen, and I was equally sad... 😞 

[CremornePt]

7 hours ago, therock said:

I met an SQ girl recently and told her to keep her current job at the frontline, stay grounded and not look to the skies yet... she was crestfallen

I'm surprised she assumed SQ would bounce back anytime soon.

Asia/Aus/NZ border restrictions will clearly remain for a long time, as most governments seem committed to ride out the pandemic by isolation.

And let's forget all the "travel bubble" nonsense. Noone seems to accept the risk. (perhaps except SG & HK, if/when they finally activate it)

Edited March 2, 2021 by CremornePt

[therock]

Vaccine inequality 

https://www.straitstimes.com/world/vip-immunisation-for-the-powerful-and-their-cronies-rattles-south-america

[Blueray]

Germany, Italy, France suspend AstraZeneca COVID-19 vaccine shots amid safety fears

Quote

BERLIN: Germany, France and Italy said on Monday (Mar 15) they would suspend AstraZeneca COVID-19 shots after several countries reported possible serious side-effects, but the World Health Organization (WHO) said there was no proven link and people should not panic.

https://www.channelnewsasia.com/news/world/astrazeneca-covid-19-vaccine-france-germany-italy-blood-clot-14414028

[Kb27]

Seems like J&J may bcum more popular, albeit it's late arrival......well until the next round of deaths reported.

Quote

https://edition.cnn.com/2021/02/16/africa/south-africa-astrazeneca-johnson-and-johnson-vaccine-intl/index.html

South Africa scraps AstraZeneca, pivots to Johnson & Johnson vaccine

(CNN)South Africa has offered its stock of Oxford-AstraZeneca Covid-19 vaccines to the African Union, a senior health official said, as the country pivots to using shots developed by Johnson & Johnson instead.

The country paused its rollout of the Oxford-AstraZeneca vaccine after preliminary trial data showed it offered minimal protection against mild to moderate illness caused by the variant of the virus that emerged in South Africa last year.

"The AU will distribute to those countries who have already expressed interest in acquiring the stock," South African Health Minister Zweli Mkhize told lawmakers in Cape Town on Tuesday.

Mkhize said that rumors the shots, which were purchased from the Serum Institute of India (SII), had expired and were being returned to India were "simply not true," and no money was wasted.

"The recent announcement around the limited efficacy of the AstraZeneca vaccine, which we had already procured, was certainly disappointing; however we were determined not to be derailed from our commitment to rollout vaccines in February," Mkhize said.

The health minister announced that the country had instead secured 9 million doses of the Johnson & Johnson vaccine.

Developed by Janssen, Johnson & Johnson's Belgium-based vaccine division, the single-dose vaccine has shown to be effective in preventing moderate and severe disease from South Africa's dominant coronavirus variant with an efficacy of 57% in trials conducted in South Africa. The B.1.351 variant was responsible for 95% of cases in that trial, and has now appeared in more than 44 countries.

"We have actually secured enough doses to vaccinate all the people who will need to be vaccinated in South Africa," said Mkhize.

South Africa is expected to green-light the Johnson & Johnson vaccine and begin administering doses this week.

The rollout marks a 180-degree pivot by South Africa, which had received 1 million doses of the Oxford-AstraZeneca Covid-19 vaccine and planned to begin administering doses to health care workers in February. Another 500,000 Oxford-AstraZeneca doses were due to be delivered by the end of the month.

Instead, South Africa has switched to a new plan. It will start vaccinating health care workers with Johnson & Johnson shots in a research study. Officials will administer shots to health workers at 20 vaccination centers in each of the country's nine provinces. More than 380,000 health workers have registered so far.

 

[Blueray]

UPDATE 2-Denmark to ditch AstraZeneca shot, delaying vaccine rollout - media

https://finance.yahoo.com/news/1-denmark-permanently-cease-using-103851581.html